Answers are grounded in this paper and cite their sources.
Despite adequate blockade of IL-1, lutikizumab did not improve pain or imaging outcomes in erosive HOA compared with placebo.
No takes yet. Share an insight, caveat, or question.
Kloppenburg et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: